Publications by authors named "Rawa Ismail"

Claim this Profile
I
Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021.
Olivier J van Not, Alfons J M van den Eertwegh, John B Haanen, Christian U Blank, Maureen J B Aarts, Rawa K Ismail

EClinicalMedicine· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors.
Olivier J van Not, Thijs T Wind, Rawa K Ismail, Arkajyoti Bhattacharya, Mathilde Jalving

Cancers (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors.
Rawa K Ismail, Karijn P M Suijkerbuijk, Anthonius de Boer, Maaike van Dartel, Doranne L Hilarius

Melanoma Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
End-of-Life Use of Systemic Therapy in Patients With Advanced Melanoma: A Nationwide Cohort Study.
Jesper van Breeschoten, Rawa K Ismail, Michel W J M Wouters, Doranne L Hilarius, Liesbeth C de Wreede

JCO Oncol Pract· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis.
Rawa Kamaran Ismail, Jesper van Breeschoten, Silvia van der Flier, Caspar van Loosen, Anna Maria Gerdina Pasmooij

J Med Internet Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort study.
Olivier J van Not, Melissa M de Meza, Alfons J M van den Eertwegh, John B Haanen, Christian U Blank, Rawa K Ismail

Eur J Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The unfavorable effects of COVID-19 on Dutch advanced melanoma care.
Olivier J van Not, Jesper van Breeschoten, Alfonsus J M van den Eertwegh, Doranne L Hilarius, Melissa M De Meza, Rawa K Ismail

Int J Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant treatment for melanoma in clinical practice - Trial versus reality.
Melissa M de Meza, Rawa K Ismail, Daan Rauwerdink, Olivier J van Not, Jesper van Breeschoten

Eur J Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An invisible group of COVID-19 victims; impact on Dutch lung cancer care.
Jesper van Breeschoten, Rawa Ismail, Hans Smit, Olga Schuurbiers, Franz Schramel

Lung Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastases.
Rawa K Ismail, Nienke O Sikkes, Michel W J M Wouters, Doranne L Hilarius, Anna M G Pasmooij

Melanoma Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of advanced melanoma patients not represented in phase III trials.
Michiel C T van Zeijl, Rawa K Ismail, Liesbeth C de Wreede, Alfonsus J M van den Eertwegh, Anthonius de Boer

Int J Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis